Table 1 Comparison of baseline characteristics between non-recurrent and recurrent HCC patients after liver transplantation.

Gender (n)

0.095

Male

225

45

Female

56

5

Age (years)

55.38 ± 0.475

52.14 ± 1.146

0.006*

HBsAg (n)

0.01*

Negative

61

3

Positive

220

47

AFP (ng/ml)

477.88 ± 164.67

4882.72 ± 2509.78

0.000*

No. of tumors (n)^a

1.94 ± 0.10

3.34 ± 0.43

0.002*

The largest size of tumor (cm)^a

3.02 ± 0.08

4.15 ± 0.43

0.003*

Macrovascular invasion (n)^a

0.000*

No

264

39

Yes

7

9

TNM staging (n)^a

0.000*

I

109

9

II

144

25

III

14

13

Milan criteria (n)^a

0.000*

Within criteria

192

20

Beyond criteria

81

29

UCSF criteria (n)^a

0.000*

Within criteria

222

21

Beyond criteria

51

28

Vascular permeation (n)^a

0.000*

No

190

18

Yes

71

29

Tumor differentiation (n)^a

0.025*

Well-differentiated

78

5

Moderately differentiated

156

33

Poorly differentiated

12

5

Undifferentiated

2

0

Graft weight to recipient ESLV (%) (n)^a

0.018*

<60%

145

35

≥60%

134

15